InteguSeal Microbial Sealant (Kimberly-Clark Worldwide Inc.) for prevention of surgical site infection
Record ID 32010000919
English
Authors' objectives:
According to guidelines prepared by the Centers for Disease Control and Prevention (CDC), 38% of all infections contracted in hospitals are surgical site infections (SSIs), making SSI the third most common cause of hospital-acquired infections. Despite improvements in infection control practices, SSI remains a significant cause of morbidity and mortality. For example, in patients who develop SSI, average hospital length of stay increases by 1 to 2 weeks.
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Anti-Bacterial Agents
- Anti-Infective Agents, Local
- Surgical Wound Infection
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.